Laura Simon Treml

Corporate Officer/Principal at ARATANA THERAPEUTICS INC

Health Technology

Consumer Services

Profile

Laura Simon Treml is currently working as the Director of Drug Development at Aratana Therapeutics, Inc. She completed her undergraduate and doctorate degrees from the University of Pennsylvania.

Laura Simon Treml active positions

Companies	Position	Start
ARATANA THERAPEUTICS INC	Corporate Officer/Principal	2013-03-25

All active positions of Laura Simon Treml

Training of Laura Simon Treml

University of Pennsylvania

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Laura Simon Treml's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Aratana Therapeutics, Inc. Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.	Health Technology